FindTrial
Sign In

Effects of high dose L-carnitine on semen parameter in infertile patients

Effects of antioxidant with high dose L-carnitine on count, morphology and motility in infertile patients semen analysis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190426043379N1
Enrollment
70
Registered
2019-06-16
Start date
2019-05-31
Completion date
Unknown
Last updated
2019-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Male infertility

Interventions

Intervention group: All patients with male factor infertility receive Androferti as a drug with high dose L-Carnitine for 3 months..

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: Age less than 45 years BMI less than 30 No smoking and drug Lack of azoospermia Sperm count is less than 15 million Sperm motility less than 32% Normal morphology less than 4%

Exclusion criteria

Exclusion criteria: Unwillingness to participate in the design or continuation of the treatment process Drug intolerance

Design outcomes

Primary

MeasureTime frame
Sperm count less than 15 million. Timepoint: Beginning of the project and after three months. Method of measurement: Laboratory.;Sperm motility less than 32%. Timepoint: Beginning of the project and after three months. Method of measurement: Laboratory.;Normal morphology less than 4%. Timepoint: Beginning of the project and after three months. Method of measurement: Laboratory.—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSalehpour Saghar

Shahid Beheshti University of Medical Sciences

S_Salehpour@sbmu.ac.ir+98 21 2303 1111

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026